Craigie James Form 4 Bloomin' Brands / James Craigie ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Craigie James

(Last) (First) (Middle)

2202 N. WEST SHORE BLVD.

SUITE 500

(Street)

TAMPA FL 33607

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bloomin' Brands, Inc. [ BLMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
Chairman

3. Date of Earliest Transaction (Month/Day/Year)
04/18/2023

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/18/2023		M		231	A	$0	46,641	D
Common Stock	04/18/2023		M		9,723	A	$0	56,364	D
Common Stock	04/18/2023		M		5,259	A	$0	61,623	D
Common Stock	04/18/2023		M		2,467	A	$0	64,090	D
Common Stock								4,040	I	By Trust(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0.0(2)	04/18/2023		A		9,236		(3)	(4)	Common Stock	9,236	$0	9,236	D
Restricted Stock Units	$0.0(2)	04/18/2023		M			231	(5)	(4)	Common Stock	231	$0	0	D
Restricted Stock Units	$0.0(2)	04/18/2023		M			9,723	(6)	(4)	Common Stock	9,723	$0	0	D
Restricted Stock Units	$0.0(2)	04/18/2023		M			5,259	(7)	(4)	Common Stock	5,259	$0	0	D
Restricted Stock Units	$0.0(2)	04/18/2023		M			2,467	(8)	(4)	Common Stock	2,467	$0	2,467	D

Explanation of Responses:

1. Represents shares held in trust for the benefit of the Reporting Person's children. The Reporting Person disclaims beneficial ownership of all such shares except to the extent of his pecuniary interest therein, and inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of such shares for purposes of Section 16 or for any other purpose.

2. Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock of the issuer upon vesting of the unit.

3. These RSUs, in the original grant amount of 9,236, will fully vest immediately prior to the issuer's annual meeting of stockholders in 2024.

4. This field is not applicable.

5. On April 18, 2022, the Compensation Committee approved a $5,000 increase to the annual equity grant for the non-executive Chair of the Board. These RSUs will vest in full on the date of the first annual meeting of stockholders following the grant date.

6. These RSUs, in the original grant amount of 9,723, will fully vest immediately prior to the issuer's annual meeting of stockholders in 2023.

7. These RSUs, in the original grant amount of 15,776, vest in three equal installments immediately prior to the issuer's annual meeting of stockholders each year beginning in 2021.

8. These RSUs, in the original grant amount of 7,400, vest in three equal installments immediately prior to the issuer's annual meeting of stockholders each year beginning in 2022.

Remarks:

	/s/ Kelly Lefferts, Attorney in Fact	04/20/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.